FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 299:17-20 July 6, 1978 Number 1 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To determine the associations between high-density-lipoprotein cholesterol levels and use of oral contraceptives or of noncontraceptive estrogens and progestins we analyzed the serum levels of this lipid in 4978 women, 21 to 62 years of age. In estrogen users, the mean level was 6.7 to 15.1 mg per deciliter above the nonuser level (P less than 0.001), whereas in a group of progestin users it was 15.8 mg per deciliter below (P less than 0.001). In women using combination oral contraceptives, the level varied with the type and dose of the component steroids, in general increasing with increasing dose of estrogen and decreasing with increasing dose or potency of progestin. Thus, the net effect of use of a combination oral contraceptive on high-density-lipoprotein cholesterol depends on its formulation.

This article has been cited by other articles:

• Cust, A. E, Kaaks, R., Friedenreich, C., Bonnet, F., Laville, M., Tjonneland, A., Olsen, A., Overvad, K., Jakobsen, M. U., Chajes, V., Clavel-Chapelon, F., Boutron-Ruault, M.-C., Linseisen, J., Lukanova, A., Boeing, H., Pischon, T., Trichopoulou, A., Christina, B., Trichopoulos, D., Palli, D., Berrino, F., Panico, S., Tumino, R., Sacerdote, C., Gram, I. T., Lund, E., Quiros, J R, Travier, N., Martinez-Garcia, C., Larranaga, N., Chirlaque, M.-D., Ardanaz, E., Berglund, G., Lundin, E., Bueno-de-Mesquita, H B., van Duijnhoven, F. J B, Peeters, P. H M, Bingham, S., Khaw, K.-T., Allen, N., Key, T., Ferrari, P., Rinaldi, S., Slimani, N., Riboli, E. (2007). Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 14: 755-767 [Abstract] [Full Text]  
• (2000). Oral contraceptives and cardiovascular risk. DTB 38: 1-5 [Abstract] [Full Text]  
• Ryu, S.-J., Chien, Y.-Y. (1996). Coexistence of Cerebral Venous Sinus and Internal Carotid Artery Thrombosis Associated with Exogenous Sex Hormones A Case Report. ANGIOLOGY 47: 299-303 [Abstract]  
• Levy, R., Moskowitz, J (1982). Cardiovascular research: decades of progress, a decade of promise. Science 217: 121-129 [Abstract]